Dipyridamole enhances digoxin bioavailability via P-glycoprotein inhibition.
Verstuyft C, Strabach S, El-Morabet H, Kerb R, Brinkmann U, Dubert L, Jaillon P, Funck-Brentano C, Trugnan G, Becquemont L.
Verstuyft C, et al. Among authors: trugnan g.
Clin Pharmacol Ther. 2003 Jan;73(1):51-60. doi: 10.1067/mcp.2003.8.
Clin Pharmacol Ther. 2003.
PMID: 12545143
Clinical Trial.